Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas
Clinical trial NCT07319676 · RECRUITING
Trial details
- NCT number
- NCT07319676
- Sponsor
- National University Hospital, Singapore
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-02
- Primary completion
- 2028-10-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.